[Remote] Director, Commercial Learning and Development at Gilead Sciences

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

12+ years of work experience with a Bachelor's degree
10+ years of total experience related to training, sales, and sales management in the biotech or pharmaceuticals industry
3+ years of experience in commercial training
Bachelor's degree
Excellent verbal, written, and interpersonal skills

Responsibilities

Lead the design, development, and implementation of learning and development programs for the U.S
Lead and guide new hire orientation, onboarding, and knowledge/skill-based training
Design, develop, and deliver employee development programs with HR Business Partners
Partner with management to define training needs through determination of knowledge gaps and needs assessment
Actively seek out new, cutting-edge technology to further improve training initiatives and build efficiency
Stay abreast of and leverage Gilead best practices, and industry best practices
Support process for evaluating training effectiveness; revise training and/or training plan as needed
Identify, develop, and deploy appropriate learning mechanisms to include: instructor-led, and web-based acknowledge training
Drive strategic management of Learning Management Systems (LMS)
Incorporate motivating, creative, and interactive training techniques to enhance the training experience, in an effort to maximize learning and retention
Formulate management development criteria, programs, and management training across all therapeutic areas
Partner with senior members of various internal departments to ensure that Learning and Development understands the strategic vision of the departments
Use broad strategic thinking to analyze the characteristics of the business environment and the challenges to developing training needs
Analyze the return on investment for training expenditure in areas of concentration, and make changes to ensure training remains relevant and valuable to the business
Partner with other regional commercial operations function leads to establish highly strategic plans and objectives

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free